Clinical Trial: Seroquel XR in the Long Term Treatment of Schizophrenia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Seroquel XR in the Long Term Treatment of Schizophrenia Focus on Affective Symptoms

Brief Summary: The purpose of the study is to determine whether the Seroquel XR treatment for 6 months improves the relapse prevention in schizophrenic outpatients

Detailed Summary:
Sponsor: AstraZeneca

Current Primary Outcome:

  • Rate of patients remained relapse free after 6 months of treatment [ Time Frame: on the 60th day of treatment ]
  • Rate of patients remained relapse free after 6 months of treatment [ Time Frame: on the 180th day of treatment ]


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • connection between relapse and affective symptoms [ Time Frame: on the 60th day of treatment ]
  • connection between relapse and affective symptoms [ Time Frame: 180th day of treatment ]


Original Secondary Outcome: Same as current

Information By: AstraZeneca

Dates:
Date Received: September 14, 2010
Date Started: September 2010
Date Completion:
Last Updated: October 21, 2011
Last Verified: October 2011